Deals Shaping The Medical Industry, December 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.

Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its CE-marked oral cancer diagnostic, the OncAlert oral cancer system. Dentamed Ltd. gets rights in Slovakia and the Czech Republic; SIRAM Ltd. will sell the test in Israel; and Diamedica Ltd. will sell it in Estonia, Latvia, and Lithuania. (Nov.)

The risk assessment system consists of OncAlert oral cancer rapid point-of-care test, an oral rinse that, when expelled into a...

More from Deal-Making

More from In Vivo